Health Insurance (Accredited Pathology Laboratories—Approval) Amendment (Relevant Standards) Principles (No.2) 2025
I, Mary Warner, as delegate of the Minister for Health and Ageing, make the following Principles.
Dated 25 June 2025
Mary Warner
Assistant Secretary
Medicare Benefits and Digital Health Division
Health Resourcing Group
Department of Health, Disability and Ageing
1 Name..............................................1
2 Commencement........................................1
3 Authority............................................1
4 Schedules............................................1
Schedule 1—Amendments 2
Health Insurance (Accredited Pathology Laboratories—Approval) Principles 2017 2
This instrument is the Health Insurance (Accredited Pathology Laboratories—Approval) Amendment (Relevant Standards) Principles (No 2) 2025.
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
Commencement information | ||
Column 1 | Column 2 | Column 3 |
Provisions | Commencement | Date/Details |
1. The whole of this instrument | 1 July 2025 | 1 July 2025 |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
This instrument is made under subsection 23DNA(1) of the Health Insurance Act 1973.
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
Health Insurance (Accredited Pathology Laboratories – Approval) Principles 2017
1 Subsection 5(2) (definition of S(FC) laboratory)
Repeal the definition, substitute:
S(FC) laboratory has the same meaning as in the Requirements for Supervision in the Clinical Governance of Medical Pathology Laboratories (Eighth Edition 2025).
2 Subsections 18(3) and (5)
Omit “Requirements for Supervision in the Clinical Governance of Medical Pathology Laboratories (Seventh Edition 2023)”, substitute “Requirements for Supervision in the Clinical Governance of Medical Pathology Laboratories (Eighth Edition 2025)”.
3 Subsection 18(5) (note)
Omit “Requirements for Supervision in the Clinical Governance of Medical Pathology Laboratories (Seventh Edition 2023)”, substitute “Requirements for Supervision in the Clinical Governance of Medical Pathology Laboratories (Eighth Edition 2025)”.
4 Schedule 1 (table Item 11)
| Repeal the item and substitute: |
|
11 Requirements for cervical screening (Third Edition 2025) 2025
5 Schedule 1 (table Item 19)
| Repeal the item and substitute: |
|
19 Requirements for Supervision in the Clinical Governance
of Medical Pathology Laboratories (Eighth Edition 2025) 2025